References
- Centers for Medicare and Medicaid Services. Decision Memo for Transcatheter Aortic Valve Replacement (TAVR) (CAG-00430N). 2012; https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=257. Accessed December 7, 2017.
- Centers for Medicare and Medicaid Services. National Coverage Determination (NCD) for Transcatheter Aortic Valve Replacement (TAVR) (20.32). 2012; https://www.cms.gov/medicare-coverage-database/details/ncd-details.aspx?NCDId=355&ncdver=1&NCAId=257&ver=4&NcaName=Transcatheter+Aortic+Valve+Replacement+(TAVR)&bc=ACAAAAAACAAAAA%3d%3d&. Accessed December 7, 2017.
- Centers for Medicare and Medicaid Services . Medicare coverage with evidence development: transcatheter aortic valve replacement. 2012; https://www.cms.gov/Medicare/Coverage/Coverage-with-Evidence-Development/TAVR.html. Accessed December 7, 2017.
- Del Trigo M, Muñoz-Garcia AJ, Wijeysundera HC, et al. Incidence, timing, and predictors of valve hemodynamic deterioration after transcatheter aortic valve replacement: multicenter registry. JACC. 2016;67(6):644–655. doi:10.1016/j.jacc.2015.10.097.
- Makkar RR, Fontana G, Jilaihawi H, et al. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med. 2015;373(21):2015–2024. doi:10.1056/NEJMoa1509233.
- Holmes DR Jr, Brennan J, Rumsfeld JS, et al. Clinical outcomes at 1 year following transcatheter aortic valve replacement. JAMA. 2015;313(10):1019–1028. doi:10.1001/jama.2015.1474.
- Mack MJ, Brennan J, Brindis R, et al. Outcomes following transcatheter aortic valve replacement in the United States. JAMA. 2013;310(19):2069–2077. doi:10.1001/jama.2013.282043.
- Wooley J, Neatherlin H, Mahoney C, et al. Description of a method to obtain complete one-year follow-up in the Society of Thoracic Surgeons/American College of Cardiology transcatheter valve therapy registry. Am J Cardiol. 2018;121(6):758–761. doi:10.1016/j.amjcard.2017.11.046.
- Alfredsson J, Stebbins A, Brennan JM, et al. Gait speed predicts 30-day mortality following transcatheter aortic valve replacement: results from the Society of Thoracic Surgeons/American College of Cardiology transcatheter valve therapy registry™. Circulation. 2016;133:1351–1359. doi:10.1161/circulationaha.115.020279.
- Coylewright M, Mack MJ, Holmes DR, O’Gara PT. A call for an evidence-based approach to the heart team for patients with severe aortic stenosis. J Am Coll Cardiol. 2015;65(14):1472–1480. doi:10.1016/j.jacc.2015.02.033.
- Briffa N, Chambers JB. Biological valves in younger patients undergoing aortic valve replacement: a word of caution. Circulation. 2017;135(12):1101–1103. doi:10.1161/circulationaha.116.026385.